Hanwha Impact's book
6 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Inari | — | $2.2B | — | — | |
| Tessera Therapeutics | — | $650.0M | — | — | |
| Cellarity | — | $525.0M | — | — | |
| Ensoma | Drug Discovery | $280.0M | — | — | |
| Neutron Holdings | — | — | — | — | |
| Catalog (Biotechnology) | — | — | — | — |
Free account
See the whole book
- ·Watchlist + alerts for Hanwha Impact's activity
Create free account
No card required